32 min
Scott Howell on the Very Large Costs of Drug Utilization Management A Health Podyssey
-
- News
Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
32 min